Regain your health

Treatment of diphtheria

Tractament de la diftèria a Vall d'Hebron

In treating diphtheria, time is key. For this reason, it is important that it be administered within the first 48 hours after the symptoms appear, without waiting for confirmation of the diagnosis, which must be done in the laboratory.

Hospital o serveis complementaris relacionats

Maternity and Children's Hospital

Where to find it

Description

The treatment uses diphtheria antitoxin and antibiotic treatment using penicillin G procaine.

Healthcare specialisations
Paediatrics
Related professionals
Dr. Carlos
Rodrigo Gonzalo de Liria
Head of Department
Paediatrics
Vall d'Hebron University Hospital
Researcher
Maternal and Foetal Medicine
Vall d'Hebron Research Institute
More information
Location >
Sr. Albert
Cortés Borra
Nursing Supervisor
Paediatrics
Vall d'Hebron University Hospital
More information
Location >
Dr. Quique
Pérez
Doctor
Paediatrics
Vall d'Hebron University Hospital
More information
Location >
Sr. Xavier
Garcia Alarcon
Nurse
Paediatric Intensive Care
Vall d'Hebron University Hospital
More information
Location >
Sr. Jesus
Corrionero Alegre
Nurse
Paediatric Intensive Care
Vall d'Hebron University Hospital
More information
Location >
 
Educació sanitària relacionades
Prevenció de la diftèria a Vall d'Hebron
Health tips to prevent diphtheria
3281
 
News and events
08 Feb
1r Curso de Diagnóstico Radio-Patológico Integrado
Hora :

09.30-17.30 h
07 Feb
1r Curso de Diagnóstico Radio-Patológico Integrado
Hora :

9.00-17.30 h
Genetic predisposition favors cannabis use in people with ADHD 16/01/2019
Happy Holidays filled with #HealingActions 18/12/2018
Vall d'Hebron performs the first pancreatic tail resection with the Da Vinci robot 14/11/2018
Entrega Ajuts Recerca La Marató 2017
Five research projects on infectious diseases receive funds from La Marató de TV3 31/10/2018
Vall d'Hebron es convertirà en la seu d’ICORD, organització referent mundial en malalties minoritàries
As of 2019, Vall d'Hebron will become the headquarters of ICORD, a worldwide reference organization in rare diseases 18/10/2018
Vall d’Hebron and Daniel Bravo Foundation open the new Cystic Fibrosis Unit, a European pioneer 04/07/2018
Juvenile ALS is a very singular and rare type of Amyotrophic Lateral Sclerosis 21/06/2018
recerca, nanomedicina, vhir
A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d'Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe 26/04/2018